Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Silencing mutant SOD1 using RNAi protects against neurodegenration and extends survival in an ALS model

Article Abstract:

A lentiviral vector to mediate expression of RNAi molecules specifically targeting the human superoxide dismutase (SOD1) gene is generated. Equine infectious anemia virus (EIAV) mediated silencing of mutant SOD1 expression in vulnerable motor neuron populations using shRNA causes long-term reversal of a dominantly inherited form of amyotrphic lateral sclerosis (ALS) in a transgenic mouse model.

Author: Greensmith, Linda, Azzouz, Mimoun, Kingsman, Susan M., Ralph, G. Scott, Mitrophanous, Kyriacos A., Mazarakis, Nicholas D., Radcliffe, Pippa A., Day, Denise M., Carthy, Janine M., Leroux, Marie A., Lee, Debbie C. P., Liang-Fong Wong, Bilsland, Lynsey G.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2005
Genetic aspects, RNA, Superoxide dismutase

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Putting the heat on ALS

Article Abstract:

Investigations have shown that daily treatments with arimoclomol, a coinducer of heat shock proteins alleviate symptoms of neurodegeneration and prolongs lifespan in a mouse model of amyotrophic lateral sclerosis (ALS). This is true even administered after onset, providing a new therapeutic approach to this disease.

Author: Benn, Susanna C., Brown, Robert H. Jr
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004
Nervous system, Neurodegenerative diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

Article Abstract:

Arimoclomol, a coinducer of heat shock proteins (HSPs) prevents the progressive loss of motoneurons and muscle function in an amyotrophic lateral sclerosis (ALS) mice model. Pharmacological activation of heat shock response is found to be a successful therapeutic approach to neurodegenerative diseases like (ALS).

Author: Greensmith, Linda, Kieran, Dairin; Kalmar, Bernadett, Dick, James R.T., Riddoch-Contreras, Joanna, Burnstock, Geoffrey
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Amyotrophic lateral sclerosis, United States, Heat shock proteins
Similar abstracts:
  • Abstracts: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model
  • Abstracts: Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Learning from the gut
  • Abstracts: RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Molecular pathways to neurodegeneration
  • Abstracts: Clinical signs predict 30-month neurodevelopmental outcome after neonatal encehalopathy. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity
  • Abstracts: Delayed interval delivery and infant survival: a population-based study. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.